Get started
Author

Stephan G. Papendorp

Observed names: Stephan G F Papendorp, Stephan G Papendorp, Stephan G. F. Papendorp, Stephan Gerardus Papendorp, Stephan Papendorp
ORCID: 0000-0001-6430-1716
Observed ORCID: 0000-0001-6430-1716
OpenAlex ID: A5044384882
The Complexity of the Post-Burn Immune Response: An Overview of the Associated Local and Systemic Complications
2023 · H. Ibrahim Korkmaz, Gwendolien Flokstra, et al. · Cells · 121
PDF
Preoperative use of raltegravir-containing regimen as induction therapy: very rapid decline of HIV-1 viral load
2009 · Stephan Gerardus Papendorp, Guido E van den Berk · AIDS · 14
An in silico modeling approach to understanding the dynamics of the post-burn immune response
2024 · H. Ibrahim Korkmaz, Vivek M. Sheraton, et al. · Frontiers in Immunology · 5
Efficacy of Alkaline Phosphatase in Critically Ill Patients with COVID-19: A Multicentre Investigator-Initiated Double-Blind Randomised Placebo-Controlled Trial
2024 · Anouk Pijpe, Stephan G. Papendorp, et al. · Biomedicines · 1
PDF
Immune function in burn patients: Pathophysiology, monitoring, and emerging therapeutic strategies
2026 · H. Ibrahim Korkmaz, Dirk P. Boer, et al. · Burns
Using HAART to decrease perioperative HIV-1 transmission risk
2010 · Stephan G Papendorp, Guido E van den Berk · AIDS
[Raltegravir as first integrase inhibitor in an HIV-infection].
2009 · Stephan G F Papendorp, Kees Brinkman · PubMed
Works count: 7
Citation count: 141
H-index: 3
I10-index: 2
Year
Topic
Type